专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2004007742A2 CHROMOSOME 6 AND 9 GENES INVOLVED IN PREMATURE CANITIES 审中-公开
标题翻译：染色体6和9基因参与早疫病的研究
公开(公告)号：WO2004007742A2
公开(公告)日：2004-01-22
申请号：PCT/FR0302154
申请日：2003-07-09
申请人： OREAL , DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
IPC分类号： C12N15/09 , A61K8/00 , A61K8/60 , A61K31/7088 , A61K48/00 , A61P17/00 , A61Q5/00 , A61Q5/02 , A61Q5/06 , A61Q5/10 , C12Q1/68 , C12Q
CPC分类号： C12Q1/6883 , A61K8/606 , A61K48/00 , A61Q5/065 , C12Q1/6886 , C12Q2600/172
摘要： The invention concerns the use of at least one polynucleotide fragment comprising 18 consecutive nucleotides whereof the sequence corresponds to all or part of a human chromosome 6 gene selected among the HLAG, NT__007592.445, NT_007592.446, NT_007592.506, NT_007592.507, NT_007592.508, HSPAIB, G8, NEU1, NG22, BAT8, HLA-DMB, HLA-DMA, BRD2, HLA-DQA1, HLA-DQA2, NT_007592.588, GRM4, RNF23, FLJ22638, NT_007592.459 and NT_007592.457 genes, or whereof the sequence corresponds to all or part of the human chromosome 9 gene selected among the FREQ, NT_030046.18, NT_030046.17, GTF3C5, CEL, CELL, FS, ABO, BARHL1, DDX31, GTF3C4 and Q96MA6 genes, the use of agents capable of modifying the function attached to one of said genes, the use of expression products of one of said genes and use of agents capable of modifying the function of said expression products, for cosmetic, therapeutic or diagnostic applications.
摘要翻译：本发明涉及至少一个包含18个连续核苷酸的多核苷酸片段的用途，其中所述序列对应于选自HLAG，NT_007592.445，NT_007592.446，NT_007592.506，NT_007592.507， NT_007592.508，HSPAIB，G8，NEU1，NG22，BAT8，HLA-DMB，HLA-DMA，BRD2，HLA-DQA1，HLA-DQA2，NT_007592.588，GRM4，RNF23，FLJ22638，NT_007592.459和NT_007592.457基因，或其序列对应于选自FREQ，NT_030046.18，NT_030046.17，GTF3C5，CEL，CELL，FS，ABO，BARHL1，DDX31，GTF3C4和Q96MA6基因的全部或部分人9号染色体基因，其用途能够修饰附着于所述基因之一的功能的试剂，所述基因之一的表达产物的用途以及能够改变所述表达产物的功能的试剂的用途，用于美容，治疗或诊断应用。

2. 发明申请

WO2004007764A3 CHROMOSOME 3, 5 AND 11 GENES INVOLVED IN PREMATURE CANITIES 审中-公开
标题翻译：染色体3，5和11基因参与早育的能力
公开(公告)号：WO2004007764A3
公开(公告)日：2004-04-08
申请号：PCT/FR0302153
申请日：2003-07-09
申请人： OREAL , DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
IPC分类号： C12N15/09 , A61K8/00 , A61K8/04 , A61K8/11 , A61K8/60 , A61K8/64 , A61K8/72 , A61K31/7088 , A61K38/00 , A61K45/00 , A61K48/00 , A61P17/00 , A61P17/04 , A61Q5/00 , A61Q5/02 , A61Q5/06 , A61Q7/00 , C12Q1/68 , A61K7/06
CPC分类号： A61Q5/065 , A61K8/606 , A61K48/00 , A61Q5/00 , C12Q1/6883 , C12Q2600/148 , C12Q2600/156
摘要： The invention concerns the use of at least one polynucleotide fragment comprising at least 18 consecutive nucleotides whereof the sequence corresponds to all or part of a human chromosome 3 gene selected among KIAA1042, CCK, CACNA1D, ARHGEF3 and AL133097 or whereof the sequence corresponds to all or part of a human chromosome 5 gene selected among KLHL3, HNRPAO, CDC25C, EGR1, C5orf6, C5orf7, LOC51308, ETF1, HSPA9B, PCDHAI to PCDHA13, CSF1R, RPL7, PDGFRB, TCOF1, AL133039, CD74, RPS14, NDST1, G3BP, GLRA1, C5orf3, MFAP3, GALNTIO and FLJ11715 genes, or whereof the sequence corresponds to all or part of a human chromosome 11 gene selected among GUCYIA2, CULS, ACAT1, NPAT, ATM, AF035326, AF035327, AF035328, BC029536, FLJ20535, DRD2, ENS303941, IGSF4, LOC51092, BC010946, TAGLN, PCSK7 and ENS300650 genes, the use of agents capable of modifying the function attached to one said regions, the use of expression products of one of said regions and the use of agents capable of modifying the function of said expression products, for cosmetic, therapeutic or diagnostic applications.
摘要翻译：本发明涉及至少一个包含至少18个连续核苷酸的多核苷酸片段的用途，其中所述序列对应于选自KIAA1042，CCK，CACNA1D，ARHGEF3和AL133097中的全部或部分人染色体3基因或其序列对应于全部或部分部分选自KLHL3，HNRPAO，CDC25C，EGR1，C5orf6，C5orf7，LOC51308，ETF1，HSPA9B，PCDHAI至PCDHA13，CSF1R，RPL7，PDGFRB，TCOF1，AL133039，CD74，RPS14，NDST1，G3BP，GLRA1的人染色体5基因的一部分，C5orf3，MFAP3，GALNTIO和FLJ11715基因，或其序列对应于选自GUCYIA2，CULS，ACAT1，NPAT，ATM，AF035326，AF035327，AF035328，BC029536，FLJ20535，DRD2，ENS303941的全部或部分人染色体11基因，IGSF4，LOC51092，BC010946，TAGLN，PCSK7和ENS300650基因，能够修饰附着于一个所述区域的功能的试剂的用途，所述区域之一的表达产物的使用以及能够修饰所述功能的试剂的所述表达产物，用于美容，治疗或诊断应用。

3. 发明申请

WO2005068650A2 VARIOUS GENES IMPLICATED IN PREMATURE CANITIES 审中-公开
标题翻译：各种各样的基因都在预期的范围内
公开(公告)号：WO2005068650A2
公开(公告)日：2005-07-28
申请号：PCT/EP2005000549
申请日：2005-01-07
申请人： OREAL , DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
IPC分类号： A61K8/60 , A61K48/00 , A61Q5/00 , A61Q5/10 , C12Q1/68 , A61K7/06
CPC分类号： A61Q5/10 , A61K8/606 , C12Q1/6883 , C12Q2600/156 , C12Q2600/172
摘要： Use of at least one polynucleotide fragment comprising at least 18 consecutive nucleotides the sequence of which corresponds to all or part of the region of the human chromosome 1 included between the markers D1S2797 and D1S2868, or between the marker D1S2842 and the telomer q, or to that of the region of the human chromosome 2 included between the markers D2S149 and D2S392, or of the region of the human chromosome 2 included between the markers D2S347 and D2S142, or of the region of the human chromosome 3 included between the markers D3S3567 and D3S1277, or between the markers D3S1285 and D3S3653, or of the region of the human chromosome 4 included between the markers D4S1501 and D4S408, or of the region of the human chromosome 6 included between the markers D6S308 and D6S1581, or of the region of the human chromosome 7 included between the markers D7S657 and D7S530, or between the markers D7S1824 and D7S615, or of the region of the human chromosome 9 included between the markers D9S1677 and D9S1682, or of the region of the human chromosome 10 included between the markers D10S591 and D10S547, or of the region of the human chromosome 12 included between the markers D12S310 and D12S85, or between the markers D12S99 and D12S364, or of the region of the human chromosome 15 included between the markers D15S1040 and D15S641, or between the markers D15S978 and D15S153, or of the region of the human chromosome 16 included between the markers D16S503 and D16S516, or between the markers D16S3030 and D16S50, or of the region of the human chromosome 18 included between the markers D18S464 and D18S1102, or of the region of the human chromosome 19 included between the markers D19S216 and D19S221, or of the region of the human chromosome 20 included between the markers D20S107 and D20S100, use of agents capable of modifying the function associated with one of these regions, use of expression products of one of these regions and use of agents capable of modifying the function of these expression products for cosmetic, therapeutic or diagnostic purposes.
摘要翻译：使用至少一个包含至少18个连续核苷酸的多核苷酸片段，其序列对应于包括在标记D1S2797和D1S2868之间或标记D1S2842与调节物q之间的人染色体1的全部或部分区域，或至少标记D2S149和D2S392之间的人染色体2的区域或包含在标记D2S347和D2S142之间的人类染色体2的区域或包含在标记D3S3567和D3S1277之间的人类染色体3区域或标记D3S1285和D3S3653之间或包含在标记D4S1501和D4S408之间的人类染色体4区域或包含在标记D6S308和D6S1581之间的人类染色体6的区域之间或人类区域标记D7S657和D7S530之间或标记D7S1824和D7S615之间的染色体7或包含在标记D9S1之间的人染色体9区域 677和D9S1682，或包含在标记D10S591和D10S547之间的人类染色体10的区域，或包含在标记D12S310和D12S85之间或标记D12S99和D12S364之间或者标记D12S99和D12S364之间的区域标记D15S1040和D15S641之间或标记D15S978和D15S153之间的人染色体15或包含在标记D16S503和D16S516之间的标记D16S3030和D16S516之间的区域或标记D16S3030和D16S50之间的区域包括在标记D18S464和D18S1102之间的人类染色体18或包含在标记D19S216和D19S221之间的人类染色体19的区域或包含在标记D20S107和D20S100之间的人染色体20区域的使用的试剂能够修改与这些区域之一相关联的功能，使用这些区域之一的表达产物和使用能够修饰t的功能的试剂用于化妆品，治疗或诊断目的的表达产品。

4. 发明专利

DE60325216D1 未知
公开(公告)号：DE60325216D1
公开(公告)日：2009-01-22
申请号：DE60325216
申请日：2003-07-09
申请人： OREAL
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
IPC分类号： C12N15/09 , C12Q1/68 , A61K8/00 , A61K8/60 , A61K31/7088 , A61K48/00 , A61P17/00 , A61Q5/00 , A61Q5/02 , A61Q5/06 , A61Q5/10

5. 发明专利

AT395437T 未知
公开(公告)号：AT395437T
公开(公告)日：2008-05-15
申请号：AT05701224
申请日：2005-01-14
申请人： OREAL
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS , DERMITZAKIS EMMANOUIL
IPC分类号： C12Q1/68

6. 发明专利

FR2842104A1 Use of human polynucleotides for treatment, prevention and diagnosis of pigmentation disorders, especially premature whitening of hair, derived from chromosomes 9 or 6 未知
公开(公告)号：FR2842104A1
公开(公告)日：2004-01-16
申请号：FR0208696
申请日：2002-07-10
申请人： OREAL
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
IPC分类号： A61K8/60 , A61K48/00 , A61P17/00 , A61Q5/06 , A61Q5/10 , C12Q1/68 , A61K7/48 , A61K7/075 , A61K31/7084 , A61K31/7088
摘要： Cosmetic or therapeutic use, in the field of pigmentation, of at least one polynucleotide fragment (I), of 30-5000 nucleotides (nt) and containing at least 18 consecutive nt that correspond to all or part of specific genes present on human chromosomes 9 or 6. Cosmetic or therapeutic use, in the field of pigmentation, of at least one polynucleotide fragment (I), of 30-5000 nucleotides (nt) and containing at least 18 consecutive nt that correspond to all or part of specific genes present on human chromosomes 9 or 6. The specified genes are: (a) for chromosome 9: FREQ, NT-030046.18, NT-030046.17, GTF3C5, CEL, CELL, FS, ABO, BARLH1, DDX31, GTF3C4 and Q96MA6; and (b) for chromosome 6: HLAG, NT-007592.446, .506, .507 or .508, HSPA1B, G8, NEU1, NG22, BAT8, HLA-DMB or -DMA,BRD2, HLA-DQA1 or -DQA2, NT-007592.588, .459 or .457, GRM4, RNF23 or FLJ22638. Independent claims are also included for the following: (1) diagnosing a predisposition to premature canitis (whitening of the hair) by identifying the alleles of the specified genes; (2) use of at least one of the SNP (single-nucleotide poymorphism) markers 418620, rs302919, 913705, 931886, 429269, 2526008, 2734988, 2734967, 1419664, 2517502, rs733539, rs494620, 154973, 206779, 60071 or rs763028 for determining genes implicated in pigmentation of the skin and other external parts of the body; (3) similar use and method of a combination of at least one (I) derived from chromosome 9 and at least one derived from chromosome 6; (4) kit containing at least two (I); and (5) similar method and use using a combination of at least one (I) derived from DDX31 or GTF3C4 and at least one fragment derived from the following genes (present on chromosomes 3, 5 or 11) KIAA1042, CCK, CACNA1D, ARHGEF3, AL133097, KLHL3, HNRPA0, CDC25C, EGR1, C5orf3, 6 or 7, LOC51308, ETF1, HSPA9B, PCDHA1 to 13, CSF1R, RPL7, PDGFRB, TCOF1, AL133039, CD74, RPS14, NDST1, G3BP, GLRA1, MFAP3, GALNT10, FLJ11715, GUCY1A2, CUL5, ACAT1, NPAT, ATM, AF035326, AF035327, AF035328, BC029536, FLJ20535, DED2, ENS303941, IGSF4, LOC51092, BC010946, TAGLN, PCSK7 or ENS300650. ACTIVITY : Dermatological. No details of tests for dermatological activity are given. MECHANISM OF ACTION : Modulating gene expression or activity of encoded products.

7. 发明专利

ES2306078T3 POLIMORFISMOS DEL CROMOSOMA 9 IMPLICADOS EN LA CANICIE PREMATURA. 未知
公开(公告)号：ES2306078T3
公开(公告)日：2008-11-01
申请号：ES05701224
申请日：2005-01-14
申请人： OREAL
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS , DERMITZAKIS EMMANOUIL
IPC分类号： C12Q1/68
摘要： Utilización de por lo menos un marcador SNP del cromosoma humano 9, seleccionado de entre los marcadores siguientes: rs306534, rs3739902, rs575916 y rs365297, para el diagnóstico de una predisposición a la canicie prematura en un individuo.

8. 发明专利

CA2551144A1 POLYMORPHISMS OF CHROMOSOME 9 IMPLICATED IN PREMATURE CANITIES 未知
公开(公告)号：CA2551144A1
公开(公告)日：2005-07-28
申请号：CA2551144
申请日：2005-01-14
申请人： OREAL
发明人： BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , DERMITZAKIS EMMANOUIL , ANTONARAKIS STYLIANOS , DE LACHARRIERE OLIVIER
IPC分类号： C12Q1/68
摘要： The invention relates to the use of at least one of the 4 SNP markers rs306534, rs3739902, rs575916 and rs365297 for carrying out a diagnosis, a process for diagnosing a predisposition to premature canities, the use of a means for determining the alleles of the 4 markers with a view to a diagnosi s and a kit for the diagnosis, a process for the diagnosis of a predisposition to premature canities based on the haplotype defined by the markers rs373990 2, rs2583805 and rs377090 and the use of at least one polynucleotide fragment comprising at least 18 consecutive nucleotides, the sequence of which corresponds to all or part of the region in a non-human mammal homologous to that of the human chromosome 9 defined by the SNP markers rs306534 and rs365297 for the diagnosis of a predisposition to premature canities in said mammal.

9. 发明专利

FR2842105A1 未知
公开(公告)号：FR2842105A1
公开(公告)日：2004-01-16
申请号：FR0208697
申请日：2002-07-10
申请人： OREAL
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS
IPC分类号： C12N15/09 , A61K8/00 , A61K8/04 , A61K8/11 , A61K8/60 , A61K8/64 , A61K8/72 , A61K31/7088 , A61K38/00 , A61K45/00 , A61K48/00 , A61P17/00 , A61P17/04 , A61Q5/00 , A61Q5/02 , A61Q5/06 , A61Q7/00 , C12Q1/68 , A61K7/48 , A61K7/075 , A61K31/7084

10. 发明专利

CA2551144C POLYMORPHISMS OF CHROMOSOME 9 IMPLICATED IN PREMATURE CANITIES 未知
公开(公告)号：CA2551144C
公开(公告)日：2010-08-24
申请号：CA2551144
申请日：2005-01-14
申请人： OREAL
发明人： DE LACHARRIERE OLIVIER , BLOUIN JEAN-LOUIS , DELOCHE CLAIRE , ANTONARAKIS STYLIANOS , DERMITZAKIS EMMANOUIL
IPC分类号： C12Q1/68
摘要： The invention relates to the use of at least one of the 4 SNP markers rs306534, rs3739902, rs575916 and rs365297 for carrying out a diagnosis, a process for diagnosing a predisposition to premature canities, the use of a means for determining the alleles of the 4 markers with a view to a diagnosis and a kit for the diagnosis, a process for the diagnosis of a predisposition to premature canities based on the haplotype defined by the markers rs3739902, rs2583805 and rs377090 and the use of at least one polynucleotide fragment comprising at least 18 consecutive nucleotides, the sequence of which corresponds to all or part of the region in a non-human mammal homologous to that of the human chromosome 9 defined by the SNP markers rs306534 and rs365297 for the diagnosis of a predisposition to premature canities in said mammal.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式